Skip to main content
Clinical Trials/NL-OMON40569
NL-OMON40569
Completed
Not Applicable

Remifentanil use for procedural sedation and analgesia in the emergency department - Remifentanil use for PSA in the emergency department

Albert Schweitzer Ziekenhuis0 sites60 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
discharge from hospital
Sponsor
Albert Schweitzer Ziekenhuis
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • All the patients who need procedural sedation and analgesia at the emergency department or the observatorium of the Albert Schweitzer hospital location Dordwijk in Dordrecht, age 18 years and older, classified as ASA I en II.

Exclusion Criteria

  • Age under 18 years, hemodynamic and/or respiratory instable, classified as ASA III, IV and V, suspicion of elevated intra\-cranial pressure, pregnancy, use of opiates at home, opiates administered before PSA procedure started (in the ambulance, on arrival at the emergency department), intoxication, known allergy for fentanyl propofol remifentanil soy or chicken proteins

Outcomes

Primary Outcomes

Not specified

Similar Trials